Profile
Sector:
HealthcareCountry:
United StatesIPO:
21 July 2017Website:
http://petiq.comNext earnings report:
07 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 25 Oct 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
PETQ Latest News
EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion.
Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
PetIQ (PETQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PetIQ, Inc. (NASDAQ: PETQ) to Bansk Group for $31.00 per share in cash is fair to PetIQ shareholders. Halper Sadeh encourages PetIQ shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether PetIQ and its board of directo.
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc . ( Nasdaq : PETQ ) , relating to its proposed merger with Bansk Group. Under the terms of the agreement, PetIQ shares will be automatically converted into the right to receive $31.00 in cash per share.
MILWAUKEE, Aug. 7, 2024 /PRNewswire/ -- Ademi LLP is investigating PetIQ (Nasdaq: PETQ) for possible breaches of fiduciary duty and other violations of law in its transaction with Bansk. Click here to learn how to join our investigation https://www.ademilaw.com/case/petiq-inc or call Guri Ademi toll-free at 866-264-3995.
What type of business is PetIQ?
PetIQ, Inc. produces medicines for pets. The company offers prescription drugs for pets, including treatments for arthritis, thyroid gland, diabetes, pain relief, as well as medications for heartworm prevention, antibiotics, and other specialty drugs, as well as over-the-counter medications and accessories, such as flea and tick control products in various forms, including spot treatments, chewable tablets, and collars. It also provides wellness services and wellness products, which include dental procedures and dietary supplements. The company was founded in 2010 and its headquarters is located in Eagle, Idaho.
What sector is PetIQ in?
PetIQ is in the Healthcare sector
What industry is PetIQ in?
PetIQ is in the Drug Manufacturers - Specialty & Generic industry
What country is PetIQ from?
PetIQ is headquartered in United States
When did PetIQ go public?
PetIQ initial public offering (IPO) was on 21 July 2017
What is PetIQ website?
https://petiq.com
Is PetIQ in the S&P 500?
No, PetIQ is not included in the S&P 500 index
Is PetIQ in the NASDAQ 100?
No, PetIQ is not included in the NASDAQ 100 index
Is PetIQ in the Dow Jones?
No, PetIQ is not included in the Dow Jones index
When was PetIQ the previous earnings report?
No data
When does PetIQ earnings report?
The next expected earnings date for PetIQ is 07 November 2024